Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 3/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.42 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.38 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.38 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | DGAT2 | Q96PD7 | 3/20 | 0.37 |
| ▸ | TDO2 | P48775 | 2/20 | 0.37 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.36 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.36 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.36 |
| ▸ | ATP1B2 | P14415 | 1/20 | 0.36 |
| ▸ | ATP1A2 | P50993 | 1/20 | 0.36 |
| ▸ | ATP1B3 | P54709 | 1/20 | 0.36 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.36 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1102540 | 0.95 | CYP17A1 (0.44) | CYP17A1CYP11B2CYP19A1CYP11B1TDO2 | |
| SCHEMBL1102457 | 0.92 | CYP17A1 (0.44) | CYP17A1CYP11B2CYP19A1CYP11B1MAPK13 | |
| SCHEMBL1102477 | 0.91 | CYP17A1 (0.43) | CYP17A1CYP11B2CYP19A1CYP11B1MAPK13 | |
| SCHEMBL1102468 | 0.90 | CYP17A1 (0.46) | CYP17A1CYP11B2CYP19A1CYP11B1MAPK14 | |
| SCHEMBL1102810 | 0.88 | CYP11B1 (0.54) | CYP17A1CYP11B2CYP19A1CYP11B1TDO2 | |
| SCHEMBL1102926 | 0.88 | CYP11B1 (0.54) | CYP17A1CYP11B2CYP19A1CYP11B1TDO2 | |
| SCHEMBL1102788 | 0.88 | CYP11B1 (0.54) | CYP17A1CYP11B2CYP19A1CYP11B1TDO2 | |
| SCHEMBL1102774 | 0.88 | CYP11B1 (0.54) | CYP17A1CYP11B2CYP19A1CYP11B1TDO2 | |
| SCHEMBL1102704 | 0.88 | CYP11B1 (0.54) | CYP17A1CYP11B2CYP19A1CYP11B1TDO2 | |
| SCHEMBL1102671 | 0.88 | CYP11B1 (0.54) | CYP17A1CYP11B2CYP19A1CYP11B1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153279-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2012-04-10 | — | — | US | disclosed |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ORMDL3, OCIAD2, OCIAD1 | CYP17A1 2034/4885CYP11B2 652/4885CYP19A1 1424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.